On 22 June, Larry Ellison adopted a plan to sell up to 50 million shares of Oracle, the company he co-founded and in which he controls roughly 40 percent. The plan was scheduled to run until 24 October.
Nobody outside the company knew until Friday, when Oracle filed its quarterly report and the plan appeared in it. At Friday's close, 50 million shares were worth about $7.5 billion. When the plan was adopted they had been worth about $8.75 billion; the stock has fallen roughly 16 percent since.
On Saturday, from Austin, Oracle issued a two-sentence announcement. Ellison had cancelled the plan. "No Oracle stock was sold under that plan, and he has no other plans to sell any of his Oracle stock."
What the plan was for
A Rule 10b5-1 plan is how corporate insiders sell stock without being accused of trading on what they know. The insider sets the terms in advance — how many shares, at what prices, over what period — and then the sales happen on that schedule regardless of what the insider later learns.
The SEC tightened the rules in December 2022. Directors and officers must now wait through a cooling-off period before any sale under a new plan, and companies must disclose in their quarterly reports when such plans are adopted or terminated. That is why a plan adopted in June first became visible in September: the disclosure arrives with the 10-Q covering the quarter in which it happened.
Why the numbers read badly
The arithmetic is simple and it was always going to be noticed.
Fifty million shares at $8.75 billion implies roughly $175 a share when the plan was adopted. At $7.5 billion it is roughly $150. A founder arranging to sell before a fall of that size looks prescient whether or not he knew anything, and the plan exists precisely so that the appearance does not matter legally.
It surfaced alongside other unwelcome news. The same filing showed that Oracle had added about $700 million to its 2026 restructuring plan, bringing the estimated cost to roughly $2.8 billion, and the shares fell 1.7 percent on Friday after the company reported shrinking gross margins. Oracle has been under investor pressure over the scale of its spending on AI data-centre capacity for customers including OpenAI — which, on the same weekend, said it would not go public this year.
What the cancellation says
A sale plan is designed to say nothing. Cancelling one the day after it became public says something.
It tells investors that the founder, or the company on his behalf, judged the market's reading of the disclosure to be costly enough to reverse. The statement that he has "no other plans to sell" is a reassurance aimed at exactly that reading. It is a reasonable thing to want to say about a company in which one person holds two-fifths of the equity.
It also carries a cost of its own. The value of the 10b5-1 framework to everyone who uses it rests on plans being treated as schedules, not options to be withdrawn when the reaction is poor. A cancellation is lawful — terminations are anticipated by the rules, disclosed in the next quarterly filing, and any new plan starts a fresh cooling-off period — but a high-profile reversal within a day invites the question of what a plan is for if it can be abandoned on reception.
What the stake is and is not
Fifty million shares is a small fraction of a holding of roughly 40 percent. Even completed in full, the sale would not have changed who controls Oracle. The significance was never the size. It was the signal a founder's sale sends about a company whose valuation is increasingly a bet on AI infrastructure that pays for itself on a schedule the depreciation does not wait for.
What to watch
Oracle's next quarterly filing, which should record the termination, and any Form 4 filings, which would show any sale or transfer of Ellison's shares outside the plan. More important for the stock is the item that shared the filing with the plan: whether the restructuring estimate grows again, and whether gross margin stabilises as the new capacity comes into service.
The adoption by Lawrence J. Ellison on 22 June 2026 of a trading plan intended to permit the sale of up to 50 million shares, its scheduled termination on 24 October 2026, and the restructuring estimates of $2.1 billion as of 31 August 2026 supplemented by approximately $700 million are from Oracle's Form 10-Q for the quarter ended 31 August 2026 filed with the SEC. The cancellation and the quoted statement are from Oracle's announcement dated Austin, Texas, 12 September 2026. The value of about $7.5 billion at Friday's close, about $8.75 billion at adoption, the decline of roughly 16 percent, Ellison's control of about 40 percent of the company, and the 1.7 percent fall on Friday after the company reported shrinking gross margins are as reported by Bloomberg and CNBC on 11 and 12 September. The description of the SEC's Rule 10b5-1 requirements refers to the amendments adopted in December 2022. The analysis is our own.
Topics marketsdisclosure
